The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists Reply

被引：0
|
作者：
Friedland, Sayuri [1 ]
Filion, Kristian B. [1 ,2 ]
Eisenberg, Mark J. [1 ,3 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada
[3] McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada
来源：
AMERICAN JOURNAL OF MEDICINE | 2013年 / 126卷 / 03期
关键词：
RISK;
D O I：
10.1016/j.amjmed.2012.10.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E13 / E13
页数：1
相关论文
共 50 条
  • [21] Roles of peroxisome proliferator-activated receptor γ in cardiovascular disease
    Takano, H
    Komuro, I
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2002, 16 (01) : 108 - 114
  • [22] Discovery, design, and synthesis of peroxisome proliferator-activated receptor δ agonists
    Chin, Jungwook
    Lee, Geumwoo
    Hwang, Hoosang
    Kang, Heonjoong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [23] Rhodanine derivatives as novel peroxisome proliferator-activated receptor γ agonists
    Qing LIU
    Acta Pharmacologica Sinica, 2007, (12) : 2033 - 2039
  • [24] Peroxisome proliferator-activated receptor gamma agonists in renal disease
    Iglesias, Pedro
    Diez, Juan J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (05) : 613 - 621
  • [25] Rhodanine derivatives as novel peroxisome proliferator-activated receptor γ agonists
    Qing Liu
    Yue-yun Zhang
    Hui-li Lu
    Qun-yi Li
    Cai-hong Zhou
    Ming-wei Wang
    Acta Pharmacologica Sinica, 2007, 28 : 2033 - 2039
  • [26] Design and synthesis of novel peroxisome proliferator-activated receptor δ agonists
    Jung, Kyungjin
    Kim, Kyung-Hee
    Cho, Sung Jin
    Chin, Jungwook
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [27] Two homoisoflavonoids act as peroxisome proliferator-activated receptor agonists
    Lin, Hsiang-Ru
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (07) : 2898 - 2905
  • [28] Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
    Olefsky, JM
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04): : 467 - 472
  • [29] Peroxisome proliferator-activated receptor delta and cardiovascular disease
    Ehrenborg, Ewa
    Skogsberg, Josefin
    ATHEROSCLEROSIS, 2013, 231 (01) : 95 - 106
  • [30] Rhodanine derivatives as novel peroxisome proliferator-activated receptor γ agonists
    Liu, Qing
    Zhang, Yue-yun
    Lu, Hui-li
    Li, Qun-yi
    Zhou, Cai-hong
    Wang, Ming-wei
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (12) : 2033 - 2039
12345